retatrutide type 2 diabetes trial results Shows Promising in and Obesity | Michael Weintraub, MD posted on the topic Retatrutide Phase 3 Results: Trials,

If your organization is actively recruiting in competitive talent markets or is thinking through a parental leave update ahead of open enrollment, that post is worth reading closely

It is suggested that a regular intake might be beneficial, but any significant changes in health outcomes shall be considered over time and in consultation with healthcare professionals

These findings suggest that re-infusion of autologous APP-treated serum may be developed as a novel antioxidant therapy, with potential applications in age-related cardio/cerebrovascular protection

NICE recommends GLP-1 medications for type 2 diabetes when other treatments have not achieved adequate control, or for weight management in adults with a BMI of 30 kg/m or above (with weight-related comorbidities) as part of a specialist multidisciplinary service

doi:10.1111/cas.13380 2022 The Author(s)

Increased Intestinal Permeability in Older Subjects Impacts the Beneficial Effects of Dietary Polyphenols by Modulating Their Bioavailability